Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival
Language English Country Great Britain, England Media print-electronic
Document type Letter, Comment
Grant support
MUNI/A/1600/2020
Lékařská fakulta, Masarykova univerzita
870177
European Reference Network for Neuromuscular Diseases
Univerzita Karlova v Praze
GIP-20-L-14-212
General University Hospital in Prague
1. Lékařská Fakulta v Praze, Univerzita Karlova
MH CZ-DRO-VFN64165
Ministerstvo Zdravotnictví Ceské Republiky
FNBr, 65269705
General University Hospital in Prague and Ref. RVO
PubMed
34699086
PubMed Central
PMC8653190
DOI
10.1111/ene.15158
Knihovny.cz E-resources
- MeSH
- COVID-19 * MeSH
- Humans MeSH
- Myasthenia Gravis * complications MeSH
- SARS-CoV-2 MeSH
- Thymectomy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Comment MeSH
Department of Neurology ERN EURO NMD Center University Hospital Brno Brno Czech Republic
Department of Rehabilitation University Hospital Brno Brno Czech Republic
See more in PubMed
Galassi G, Marchioni A. Comment on 'Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic status and survival' by Jakubíková et al. Eur J Neurol. 2021;29(1):e5‐e6. 10.1111/ene.15131 PubMed DOI PMC
Jakubíková M, Týblová M, Tesař A, et al. Predictive factors for a severe course of COVID‐19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival. Eur J Neurol. 2021;28(10):3418‐3425. PubMed PMC
Ziehr DR, Alladina J, Petri CR, et al. Respiratory pathophysiology of mechanically ventilated patients with COVID‐19: a cohort study. Am J Respir Crit Care Med. 2020;201(12):1560‐1564. PubMed PMC
Fan E, Beitler JR, Brochard L, et al. COVID‐19‐associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med. 2020;8:816‐821. PubMed PMC
RECOVERY Collaborative Group , Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with Covid‐19. N Engl J Med. 2021;384(8):693‐704. PubMed PMC
Stastna D, Menkyova I, Drahota J, et al. Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID‐19: a pandemic year in Czechia. Mult Scler Relat Disord. 2021;24(54):103104. PubMed PMC
